Clinical trial
Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic
NCT01433887 is registered in ClinicalTrials.gov with Third Affiliated Hospital, Sun Yat-Sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic
- Lead sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- June 30, 2014
- Enrollment
- 535 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
chronic hepatitis c